IL171987A0 - The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma - Google Patents
The use of fumaric acid derivatives for treating cardiac insufficiency, and asthmaInfo
- Publication number
- IL171987A0 IL171987A0 IL171987A IL17198705A IL171987A0 IL 171987 A0 IL171987 A0 IL 171987A0 IL 171987 A IL171987 A IL 171987A IL 17198705 A IL17198705 A IL 17198705A IL 171987 A0 IL171987 A0 IL 171987A0
- Authority
- IL
- Israel
- Prior art keywords
- fumaric acid
- acid derivatives
- asthma
- cardiac insufficiency
- treating cardiac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: what is presented is using fumaric acid derivatives specified in a group consisting of dialkylfumarates, monoalkylhydrofumarates, fumaric acid monoalkyl ester salts, fumaric acid monoamides, fumaric acid monoamide salts, fumaric acid diamides, monoalkyl monoamido fumarates, carbocyclic and oxacarbocyclic oligomers of these compounds or their mixtures for preparing a drug for treatment or prevention of cardiac failure, particularly left-ventricular failure, myocardial infarction and angina. ^ EFFECT: dimethylfumarate has appeared to reduce considerably an area of infarction caused by ischemia followed by reperfusion. ^ 19 cl, 4 dwg, 7 ex
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10341530 | 2003-09-09 | ||
DE10360869A DE10360869A1 (en) | 2003-09-09 | 2003-12-23 | Use of fumaric acid derivatives for the treatment of heart failure, hyperkeratosis and asthma |
PCT/EP2004/009835 WO2005023241A1 (en) | 2003-09-09 | 2004-09-03 | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
IL171987A0 true IL171987A0 (en) | 2006-04-10 |
IL171987A IL171987A (en) | 2010-12-30 |
Family
ID=34258515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL171987A IL171987A (en) | 2003-09-09 | 2005-11-15 | Use of fumaric acid derivatives for preparing a drug for treating or prevention of cardiac insufficiency, myocardial infarct and angina pectoris |
Country Status (12)
Country | Link |
---|---|
JP (3) | JP2008529959A (en) |
CN (2) | CN1829505B (en) |
AT (1) | ATE447946T1 (en) |
CY (1) | CY1107849T1 (en) |
DE (2) | DE10360869A1 (en) |
HK (1) | HK1094650A1 (en) |
IL (1) | IL171987A (en) |
NZ (1) | NZ543708A (en) |
PT (1) | PT1663197E (en) |
RS (1) | RS51881B (en) |
RU (2) | RU2459621C2 (en) |
ZA (1) | ZA200601985B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ602496A (en) | 2008-08-19 | 2013-09-27 | Xenoport Inc | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
EP3295936A1 (en) * | 2009-01-09 | 2018-03-21 | Forward Pharma A/S | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
HK1252751A1 (en) * | 2009-01-09 | 2019-05-31 | Fwp Ip Aps | Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix |
EP2782561A1 (en) * | 2011-11-24 | 2014-10-01 | Synthon BV | Controlled release particles comprising dimethyl fumarate |
US20130216615A1 (en) * | 2012-02-07 | 2013-08-22 | David Goldman | Pharmaceutical Compositions Containing Dimethyl Fumarate |
WO2014031897A1 (en) | 2012-08-22 | 2014-02-27 | Xenoport, Inc. | Oral dosage forms having a high loading of (n,n- diethylcarbamoyl)methyl methyl|(2e)but-2-ene-1,4-dioate |
US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
KR101379427B1 (en) * | 2013-02-13 | 2014-03-28 | 경북대학교병원 | Composition for preventing or treating renal fibrosis comprising dimethylfumarate |
US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
WO2014197860A1 (en) | 2013-06-07 | 2014-12-11 | Xenoport, Inc. | Method of making monomethyl fumarate |
WO2014205392A1 (en) | 2013-06-21 | 2014-12-24 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
JP2016534133A (en) | 2013-09-06 | 2016-11-04 | ゼノポート,インコーポレイティド | Crystal form of (N, N-diethylcarbamoyl) methyl methyl (2E) but-2-ene-1,4-dioate, its synthesis and use |
WO2015042294A1 (en) * | 2013-09-18 | 2015-03-26 | Xenoport, Inc. | Nanoparticle compositions of dimethyl fumarate |
US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242905A (en) * | 1987-09-04 | 1993-09-07 | Dexter Chemical Corporation | Pharmaceutical compositions for the treatment of psoriasis |
US4959389A (en) * | 1987-10-19 | 1990-09-25 | Speiser Peter P | Pharmaceutical preparation for the treatment of psoriatic arthritis |
AU5474198A (en) * | 1996-12-24 | 1998-07-17 | National Research Council Of Canada | Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
DE19721099C2 (en) * | 1997-05-20 | 1999-12-02 | Fumapharm Ag Muri | Use of fumaric acid derivatives |
DE19814358C2 (en) * | 1998-03-31 | 2002-01-17 | Fumapharm Ag Muri | Use of alkyl hydrogen fumarates for the treatment of psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis Crohn |
DE19839566C2 (en) * | 1998-08-31 | 2002-01-17 | Fumapharm Ag Muri | Use of fumaric acid derivatives in transplant medicine |
DE19853487A1 (en) * | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Use of dialkyl fumarate for treating transplant rejection and autoimmune disease |
DE10101307A1 (en) * | 2001-01-12 | 2002-08-01 | Fumapharm Ag Muri | Fumaric acid derivatives as NF-kappaB inhibitor |
EP1372634B1 (en) * | 2001-01-12 | 2009-11-11 | Biogen Idec International GmbH | Use of fumaric acid amides |
RU2189813C1 (en) * | 2001-06-01 | 2002-09-27 | Российский научно-исследовательский институт гематологии и трансфузиологии | Antihypoxic medicinal agent |
DE10217314A1 (en) * | 2002-04-18 | 2003-11-13 | Fumapharm Ag Muri | Carbocyclic and oxacarboncyclic fumaric acid oligomers |
-
2003
- 2003-12-23 DE DE10360869A patent/DE10360869A1/en not_active Withdrawn
-
2004
- 2004-09-03 DE DE602004024143T patent/DE602004024143D1/en active Active
- 2004-09-03 CN CN2004800217249A patent/CN1829505B/en not_active Expired - Fee Related
- 2004-09-03 PT PT04764790T patent/PT1663197E/en unknown
- 2004-09-03 AT AT07121903T patent/ATE447946T1/en not_active IP Right Cessation
- 2004-09-03 JP JP2006515290A patent/JP2008529959A/en active Pending
- 2004-09-03 CN CN2010102746278A patent/CN102058574B/en not_active Expired - Fee Related
- 2004-09-03 NZ NZ543708A patent/NZ543708A/en unknown
- 2004-09-03 RS YU20050948A patent/RS51881B/en unknown
-
2005
- 2005-11-15 IL IL171987A patent/IL171987A/en not_active IP Right Cessation
-
2006
- 2006-03-08 ZA ZA200601985A patent/ZA200601985B/en unknown
-
2007
- 2007-02-14 HK HK07101740.4A patent/HK1094650A1/en not_active IP Right Cessation
- 2007-10-15 RU RU2007138216/15A patent/RU2459621C2/en not_active IP Right Cessation
-
2008
- 2008-01-08 CY CY20081100024T patent/CY1107849T1/en unknown
-
2009
- 2009-12-24 JP JP2009292569A patent/JP5784877B2/en not_active Expired - Fee Related
-
2012
- 2012-04-19 RU RU2012115860/15A patent/RU2012115860A/en not_active Application Discontinuation
-
2015
- 2015-06-04 JP JP2015113701A patent/JP2015155480A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1829505A (en) | 2006-09-06 |
JP2008529959A (en) | 2008-08-07 |
ZA200601985B (en) | 2007-05-30 |
RU2012115860A (en) | 2013-10-27 |
JP2015155480A (en) | 2015-08-27 |
CY1107849T1 (en) | 2013-06-19 |
CN102058574B (en) | 2013-02-13 |
DE10360869A1 (en) | 2005-04-07 |
CN1829505B (en) | 2010-11-10 |
RS51881B (en) | 2012-02-29 |
RS20050948A (en) | 2008-04-04 |
PT1663197E (en) | 2007-12-26 |
HK1094650A1 (en) | 2007-04-04 |
JP5784877B2 (en) | 2015-09-24 |
NZ543708A (en) | 2008-11-28 |
DE602004024143D1 (en) | 2009-12-24 |
CN102058574A (en) | 2011-05-18 |
ATE447946T1 (en) | 2009-11-15 |
IL171987A (en) | 2010-12-30 |
RU2007138216A (en) | 2009-04-20 |
JP2010070563A (en) | 2010-04-02 |
RU2459621C2 (en) | 2012-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL171987A0 (en) | The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma | |
AU2016366220B2 (en) | Compounds useful in the treatment and/or care of the skin, hair, nails, and/or mucous membranes | |
EA200101166A1 (en) | Metalloprotease inhibitors | |
ME01310B (en) | Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes | |
CA2414967A1 (en) | Valproic acid and derivatives thereof as histone deacetylase inhibitors | |
TR200200648T2 (en) | New dicarboxylic acid derivatives with pharmaceutical properties. | |
MY161092A (en) | 3h-imidazo [4, 5 -c] pyridine- 6 - carboxamides as anti- inflammatory agents | |
EP1592665A4 (en) | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | |
RU94040170A (en) | Isoquinolines | |
SG154333A1 (en) | The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases | |
EA200801492A1 (en) | PHARMACEUTICAL APPLICATION OF SUBSTITUTED AMIDES | |
MY146662A (en) | Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain | |
UA105018C2 (en) | Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition | |
ITRM20020014A1 (en) | DERIVATIVES OF A-PHENYLTHIOCARBOXYL AND A-PHYLYOXYCARBOXYL ACIDS USEFUL FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF | |
AR036623A1 (en) | REPAGLINIDA PREPARATION PROCESS | |
ES2163805T3 (en) | DERIVATIVES OF BENZOFURAN-ACRYLIC ACIDS AND ITS USE AS MODULATORS OF RXRS OR RARS RECEIVERS. | |
CA2362833A1 (en) | Phenylalaninol derivatives | |
DE60119514D1 (en) | AMID DERIVATIVES OF 2-AMINO-3-HYDROXY-4-TERT-LEUCYL-AMINO-5-PHENYL-PENTANIC ACID | |
GEP20053636B (en) | Isoquinoline Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them | |
TR200101980T2 (en) | Arilalkanoil derivatives, their preparation processes | |
TR200102009T2 (en) | The use of compounds according to formula I for prophylaxis and treatment of cerebral process | |
TW200500342A (en) | 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxypyridin-3-yl)propyl]benz-amide, its use as a medicament, and pharmaceutical preparations comprising it | |
AR030945A1 (en) | AMIDAS OF FENILCICLOHEXANOCARBOXILICO SUBSTITUTED ACID AND USE | |
MX2009005676A (en) | Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders. | |
ATE546137T1 (en) | PHARMACEUTICAL COMPOSITIONS FOR TREATING WARTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |